SMURF2 and neoplasm: Consistently, the average weights and volumes of tumor xenografts from wild-type Smurf1- and Smurf2-expressing cells, but not the E3 ligase-defective mutants, were significantly reduced compared with those from the controls at Day 60 (Fig. 6H, I).